G. Tsakonas

发表

Immune checkpoint blockade for non-small cell lung cancer: What is the role in the special populations?

S. Ekman, R. Califano, C. Ackermann, 2019, European journal of cancer.

High incidence of thyroid cancer among patients with acromegaly.

M. Peppa, E. Diamanti-Kandarakis, G. Papadakis, 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Dabigatran plasma levels, aPTT and thromboelastography in patients with AF: implications for allowing early non-elective surgical procedures

G. Anagnostou, S. Makrygiannis, G. Tsakonas, 2017, Journal of Thrombosis and Thrombolysis.

Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation charts.

G. Tsakonas, A. Pipilis, N. Sourlas, 2007, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.

C. Stefanadis, G. Lazaros, G. Tsakonas, 2010, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.

R. Lewensohn, S. Friesland, S. Ekman, 2020, European journal of cancer.

c-MET as a biomarker in patients with surgically resected non-small cell lung cancer.

F. Hirsch, C. Rivard, S. Ekman, 2019, Lung cancer.

Cancer incidence and mortality patterns in women with anorexia nervosa

L. Ekselius, L. Brandt, A. Skalkidou, 2014, International journal of cancer.

Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc – effects and side effects

I. Lax, R. Lewensohn, P. Wersäll, 2021, Acta oncologica.

Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin Vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial)

L. Specht, S. Friesland, C. Kristensen, 2020, Cancers.

S. Ekman, O. Brustugun, P. Hydbring, 2022, Cancers.

Biomarkers for CNS metastasis in Non-Small Cell Lung Cancer (NSCLC)

G. Tsakonas, 2020 .

Management of brain metastasized non-small cell lung cancer (NSCLC) - From local treatment to new systemic therapies.

S. Ekman, L. de Petris, L. Petris, 2017, Cancer Treatment Reviews.

Novel pyrrolo[1,2-a][3.1.6]benzothiadiazocine ring synthesis. Unusual Truce–Smiles type rearrangement of 1-{[1-(2-nitrophenyl)-1H-pyrrol-2-yl]sulfonyl(or sulfinyl)}acetone

A. Kimbaris, G. Varvounis, G. Tsakonas, 2004 .

Vandetanib combined with a p38 MAPK inhibitor synergistically reduces glioblastoma cell survival

F. Pontén, S. Navani, I. Alafuzoff, 2013, Medical Oncology.

Oncogene-addicted non-small cell lung cancer and immunotherapy.

S. Ekman, G. Tsakonas, 2018, Journal of thoracic disease.

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a ‘Real-Life’ Setting

D. Mavroudis, S. Ekman, S. Agelaki, 2020, Cancers.

Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy

S. Ekman, S. Agelaki, D. Makrakis, 2021, Cancers.

Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors.

S. Friesland, S. Ekman, L. de Petris, 2021, European journal of cancer.

Complications following novel therapies for non‐small cell lung cancer

S. Ekman, K. Rounis, G. Tsakonas, 2022, Journal of internal medicine.

Primary CNS Metastatic BRAF-mutated Lung Adenocarcinoma With Complete Intracranial Response to BRAF/MEK Inhibition.

S. Ekman, G. Tsakonas, V. Grozman, 2020, Clinical lung cancer.

Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors—is it time for a paradigm shift?

I. Gunnarsson, A. Catrina, K. Chatzidionysiou, 2020, Clinical Rheumatology.

Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer

R. Lewensohn, S. Ekman, O. Brustugun, 2021, Translational lung cancer research.

Quality of life in acromegaly and the association with the clinical parameters of the disease

M. Peppa, G. Papadakis, I. Kostoglou-Athanassiou, 2017 .

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.

O. Brustugun, J. Nyman, S. Langer, 2021, The Lancet. Oncology.

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature

S. Ekman, P. Hydbring, P. Micke, 2022, International journal of molecular sciences.

ALK-Brain Prognostic Index—Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases

R. Lewensohn, S. Friesland, S. Ekman, 2020, Cancers.

Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer

R. Lewensohn, S. Friesland, S. Ekman, 2017, Acta oncologica.

Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden.

R. Lewensohn, K. Viktorsson, L. de Petris, 2018, Lung cancer.

High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC

S. Ekman, Antti Ylipää, P. Micke, 2021, Cancers.

Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis

S. Ekman, R. Califano, C. Ackermann, 2023, International journal of cancer.

Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.

S. Chakrabortty, G. Stragliotto, V. Tadigotla, 2023, Lung cancer.

PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas

F. Pontén, S. Navani, M. Bergqvist, 2014, Tumor Biology.